Cargando…
Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative virus of the coronavirus disease 2019 (COVID-19) pandemic. To establish a safe and convenient assay system for studying entry inhibitors and neutralizing antibodies against SARS-CoV-2, we constructed a codon-optimized, ful...
Autores principales: | Hu, Jie, Gao, Qingzhu, He, Changlong, Huang, Ailong, Tang, Ni, Wang, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366953/ https://www.ncbi.nlm.nih.gov/pubmed/32837985 http://dx.doi.org/10.1016/j.gendis.2020.07.006 |
Ejemplares similares
-
A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV
por: Zhao, Guangyu, et al.
Publicado: (2013) -
A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023) -
Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022) -
An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
por: Yang, Peng, et al.
Publicado: (2021) -
Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors
por: Chen, Qing, et al.
Publicado: (2018)